ES
ESMC.US Escalon Medical Corp
- Market cap
- USD 1.26M
- P/E
- 0.6x
- P/B
- 0.24x
- ROE
- 67.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2026.
Is ESMC.US undervalued?
Graham numberThe Graham number of Escalon Medical Corp cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Escalon Medical Corp fundamental analysis
No fundamental analysis for Escalon Medical Corp yet.
Escalon Medical Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Escalon Medical Corp
Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals for ophthalmic applications in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides …
Full company profileEscalon Medical Corp financial statements
Escalon Medical Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 11.2M | 11.4M | 9.63M | 9.40M | 10.5M | 10.7M | 12.2M | 12.0M | 12.0M | 12.7M |
| Gross Profit | 5.15M | 5.10M | -5.00M | 4.20M | 4.43M | 4.61M | 5.48M | 5.15M | 5.51M | 5.57M |
| Operating Income | -627K | 205K | -253K | -795K | -33.7K | -470K | 479K | -104K | 133K | 45.2K |
| EBITDA | -581K | 759K | -183K | -587K | 14.6K | 84.9K | 524K | -58.5K | 166K | 2.90M |
| Net Income | -727K | 584K | -250K | -650K | -52.0K | 18.1K | 457K | -125K | 106K | 4.01M |
| EPS | -0.10 | 0.08 | -0.03 | -0.09 | -0.01 | 0.00 | 0.06 | -0.02 | 0.01 | 0.54 |
| Balance Sheet | ||||||||||
| Total Assets | 4.98M | 5.43M | 5.13M | 5.72M | 5.68M | 5.17M | 5.31M | 4.76M | 4.99M | 9.13M |
| Total Liabilities | 3.80M | 3.01M | 2.97M | 4.21M | 4.22M | 3.69M | 3.37M | 2.95M | 3.08M | 3.20M |
| Shareholders' Equity | 1.18M | 2.41M | 2.16M | 1.51M | 1.46M | 1.48M | 1.93M | 1.81M | 1.92M | 5.93M |
| Cash & Short-term Investments | 544K | 874K | 410K | 826K | 1.65M | 594K | 890K | 209K | 546K | 3.07M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -506K | 107K | -473K | -168K | 839K | -1.05M | 325K | -603K | 381K | -403K |
| Capital Expenditure | 8.00K | 29.4K | 22.1K | 59.8K | 9.39K | 6.69K | 6.69K | 40.3K | 3.88K | 4.42K |
| Free Cash Flow | -514K | 64.9K | -495K | -228K | 829K | -1.05M | 311K | -643K | 377K | -407K |
| Ratios | ||||||||||
| ROE | -61.4% | 24.2% | -11.6% | -43.0% | -3.6% | 1.2% | 23.6% | -6.9% | 5.5% | 67.7% |
| ROA | -14.6% | 10.8% | -4.9% | -11.4% | -0.9% | 0.3% | 8.6% | -2.6% | 2.1% | 44.0% |
| Net Profit Margin | -6.5% | 5.1% | -2.6% | -6.9% | -0.5% | 0.2% | 3.8% | -1.0% | 0.9% | 31.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Escalon Medical Corp dividends
Escalon Medical Corp has not paid dividends in the last 10 fiscal years.
Last stock split: 1:4 on Nov 24, 1997.
Who owns Escalon Medical Corp
- Insiders 1.90%
- Institutions 7.91%
- Public & others 90.18%
- Shares outstanding 7.42M
- Free float 7.27M
Escalon Medical Corp company profile
- Company name
- Escalon Medical Corp
- Ticker
- ESMC.US
- Exchange
- USA Stocks
- Listed since
- Sep 11, 1992
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 40
- Fiscal year end
- June
- Address
- 994 Old Eagle School Road, Wayne, PA, United States, 19087
- Phone
- 610 688 6830
- Website
- escalonmedical.com
About Escalon Medical Corp
Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals for ophthalmic applications in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also provides Ispan Intraocular Gases, such as C3F8 and SF6 that are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and AXIS Image management system for managing ophthalmic diagnostic images through the web browser from various devices. In addition, it markets disposable surgical packs used in vitreoretinal surgery, including packs that aid surgeons in the process of injecting and extracting silicone oil. Further, the company engages in the manufacturing and distribution of patented disposable universal gas kit, which delivers the gas from the canister to the patient. It sells its products to medical institutions through independent sales representatives, network of distributors, and internal sales employees. The company was incorporated in 1987 and is based in Wayne, Pennsylvania.
Escalon Medical Corp management
3- Mr. Richard J. DePiano Jr.President, CEO, General Counsel & Chairman of Board · born 1966
- Ms. Weiying HuangChief Financial Officer · born 1979
- Mr. Mark G. WallaceCOO and Principal Financial & Accounting Officer · born 1970